NCT03245866

Brief Summary

This registry was created to assess management parameters of patients treated for aneurysmal subarachnoid hemorrhage in Switzerland. All Swiss hospitals with a neurosurgery department, an intensive care unit and an interventional neuroradiology team that treat neurovascular emergencies participate in the registry. Clinical parameters are entered into a common database. This database will provide (1) a nationwide assessment of the current standard of care and (2) the outcomes for patients in Switzerland including neuropsychological assessments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

9 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jan 2009Dec 2030

Study Start

First participant enrolled

January 1, 2009

Completed
6.6 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2015

Completed
2 years until next milestone

First Posted

Study publicly available on registry

August 10, 2017

Completed
8.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Expected
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

17 years

First QC Date

August 23, 2015

Last Update Submit

May 15, 2023

Conditions

Keywords

Subarachnoid HemorrhageIntracranial AneurysmRuptured Intracranial AneurysmNeurosurgeryInterventional NeuroradiologyNeurointensive Care MedicineSwitzerland

Outcome Measures

Primary Outcomes (1)

  • Functional outcome as assessed by the modified Rankin scale

    The modified Rankin scale is used to represent the level of disability and is divided into 7 categories (0-6). The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.

    5 years after hemorrhage

Study Arms (1)

Aneurysmal Subarachnoid hemorrhage

Patients suffering from a ruptured cerebral aneurysm are included in the study.

Other: Observational/ no intervention

Interventions

Aneurysmal Subarachnoid hemorrhage

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted in Switzerland with a diagnosis of aneurysmal subarachnoid hemorrhage

You may qualify if:

  • \- Patients admitted with a proven diagnosis of aneurysmal subarachnoid hemorrhage.

You may not qualify if:

  • \- Patients in whom the source of haemorrhage could not be identified (angiogram-negative SAH) or SAH with other causes than cerebral aneurysms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Kantonsspital Aarau

Aarau, Canton of Aargau, 5000, Switzerland

RECRUITING

Geneva University Hospital

Geneva, Canton of Geneva, 1211, Switzerland

RECRUITING

Kantonsspital St. Gallen

Sankt Gallen, Canton of St. Gallen, 9000, Switzerland

RECRUITING

University Hospital Basel

Basel, 4000, Switzerland

RECRUITING

University Hospital Bern

Bern, 3000, Switzerland

RECRUITING

University Hospital Lausanne

Lausanne, 1000, Switzerland

RECRUITING

Luzerner Kanton Spital

Lucerne, 6000, Switzerland

RECRUITING

Ospedale Civico

Lugano, 6900, Switzerland

RECRUITING

University Hospital Zürich

Zurich, 8091, Switzerland

RECRUITING

Related Publications (5)

  • Zweifel-Zehnder AE, Stienen MN, Chicherio C, Studerus-Germann A, Blasi S, Rossi S, Gutbrod K, Schmid N, Beaud V, Mondadori C, Brugger P, Sacco L, Muri R, Hildebrandt G, Fournier JY, Keller E, Regli L, Fandino J, Mariani L, Raabe A, Daniel RT, Reinert M, Robert T, Schatlo B, Bijlenga P, Schaller K, Monsch AU; Swiss SOS study group. Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations. Acta Neurochir (Wien). 2015 Sep;157(9):1449-58. doi: 10.1007/s00701-015-2480-y. Epub 2015 Jul 16.

    PMID: 26179382BACKGROUND
  • Schatlo B, Fung C, Fathi AR, Sailer M, Winkler K, Daniel RT, Bijlenga P, Ahlborn P, Seule M, Zumofen D, Reinert M, Woernle C, Stienen M, Levivier M, Hildebrandt G, Mariani L, Bernays R, Fandino J, Raabe A, Keller E, Schaller K. Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS). Acta Neurochir (Wien). 2012 Dec;154(12):2173-8; discussion 2178. doi: 10.1007/s00701-012-1500-4. Epub 2012 Oct 6.

  • Schatlo B, Fung C, Stienen MN, Fathi AR, Fandino J, Smoll NR, Zumofen D, Daniel RT, Burkhardt JK, Bervini D, Marbacher S, Reinert M, D Alonzo D, Ahlborn P, Mendes Pereira V, Roethlisberger M, Seule M, Kerkeni H, Remonda L, Weyerbrock A, Woernle K, Venier A, Perren F, Sailer M, Robert T, Rohde V, Schoni D, Goldberg J, Nevzati E, Diepers M, Gralla J, Z'Graggen W, Starnoni D, Woernle C, Maldaner N, Kulcsar Z, Mostaguir K, Maduri R, Eisenring C, Bernays R, Ferrari A, Dan-Ura H, Finkenstadt S, Gasche Y, Sarrafzadeh A, Jakob SM, Corniola M, Baumann F, Regli L, Levivier M, Hildebrandt G, Landolt H, Mariani L, Guzman R, Beck J, Raabe A, Keller E, Bijlenga P, Schaller K. Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS). Stroke. 2021 Jan;52(1):344-347. doi: 10.1161/STROKEAHA.120.029538. Epub 2020 Dec 4.

  • Stienen MN, Smoll NR, Fung C, Goldberg J, Bervini D, Maduri R, Chiappini A, Robert T, May A, Bijlenga P, Zumofen D, Roethlisberger M, Seule MA, Marbacher S, Fandino J, Schatlo B, Schaller K, Keller E, Bozinov O, Regli L; Swiss SOS Study Group. Home-Time as a Surrogate Marker for Functional Outcome After Aneurysmal Subarachnoid Hemorrhage. Stroke. 2018 Dec;49(12):3081-3084. doi: 10.1161/STROKEAHA.118.022808.

  • Stienen MN, Germans M, Burkhardt JK, Neidert MC, Fung C, Bervini D, Zumofen D, Rothlisberger M, Marbacher S, Maduri R, Robert T, Seule MA, Bijlenga P, Schaller K, Fandino J, Smoll NR, Maldaner N, Finkenstadt S, Esposito G, Schatlo B, Keller E, Bozinov O, Regli L; Swiss SOS Study Group. Predictors of In-Hospital Death After Aneurysmal Subarachnoid Hemorrhage: Analysis of a Nationwide Database (Swiss SOS [Swiss Study on Aneurysmal Subarachnoid Hemorrhage]). Stroke. 2018 Feb;49(2):333-340. doi: 10.1161/STROKEAHA.117.019328. Epub 2018 Jan 15.

MeSH Terms

Conditions

Subarachnoid HemorrhageIntracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsIntracranial Arterial DiseasesAneurysm

Study Officials

  • Karl Schaller, MD

    University Hospital, Geneva

    STUDY DIRECTOR
  • Bawarjan Schatlo, MD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR
  • Martin N Stienen, MD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR
  • Philippe Bijlenga, MD PhD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karl Schaller, MD

CONTACT

Philippe Bijlenga, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

August 23, 2015

First Posted

August 10, 2017

Study Start

January 1, 2009

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2030

Last Updated

May 16, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

N/A, observational study

Locations